NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Population Bio, Inc.

Population Bio, Inc.

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.populationbio.com/

Last Round

Grant

Nov 20, 2013

Total Funding Raised

$5.56M

Company Overview

Population Bio, Inc. is a precision medicine company that discovers disease-relevant genetic biomarkers to develop targeted therapies and companion diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Drug Discovery, Biotechnology, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

precision medicinegenetic biomarker discoverycopy number variationCNVcompanion diagnosticsdrug safetygenomic screeningdrug repurposingserious adverse eventsSAEbiotech research servicesgenomics platformdrug rescuein-silico discoverypharma R&D

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Population Bio, Inc. Comparables

Compare Population Bio, Inc. with similar companies based on industry and business-model similarity.

Population Bio, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Sequence Bio
79%
Amgen
71%
Enhanced Genomics
67%

Population Bio, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 20, 2013
Series AAug 1, 2011
GrantMay 17, 2010

Key People

Founding team and executive leadership

Peggy Eis

Co-Founder and Chief Technology Officer

Founding Team

Jim Chinitz

CEO

Executive Team

Population Bio, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2011

    $5.36M round completed.

Population Bio, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Population Bio, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Population Bio, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Employee Range2
Year Founded2006
Last FundingNov 20, 2013

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.